» Authors » Christopher Harding

Christopher Harding

Explore the profile of Christopher Harding including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 466
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Feeney C, Gorman G, Stefanetti R, McFarland R, Turnbull D, Harding C, et al.
Neurourol Urodyn . 2020 Sep; 39(8):2253-2263. PMID: 32969525
Aims: Mitochondrial diseases present with a spectrum of clinical features, usually with multiorgan involvement and are often characterized by a loss of smooth muscle function. Hence, we hypothesized that mitochondrial...
12.
Ribal M, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, et al.
Eur Urol . 2020 May; 78(1):21-28. PMID: 32376137
The coronavirus disease 2019 (COVID-19) pandemic is unlike anything seen before by modern science-based medicine. Health systems across the world are struggling to manage it. Added to this struggle are...
13.
Giarenis I, Anding R, Chermansky C, Greenwell T, Cardozo L, Harding C
Neurourol Urodyn . 2020 Feb; 39 Suppl 3:S122-S131. PMID: 32022954
Background: Synthetic midurethral sling (MUS) procedures, purported for the last two decades as the gold standard surgical treatment for stress urinary incontinence, have been in creasingly scrutinized in recent years...
14.
Rademakers K, Gammie A, Yasmin H, Cardozo L, Greenwell T, Harding C, et al.
Neurourol Urodyn . 2020 Jan; 39 Suppl 3:S30-S35. PMID: 31961959
Aims: Lower urinary tract (LUT) function can be investigated by urodynamic studies (UDS) to establish underlying functional abnormalities in the LUT. A multicentre registry could present an opportunity to improve...
15.
Giarenis I, Malde S, Harding C, Robinson D, Gajewski J, Rahnamai M, et al.
Neurourol Urodyn . 2019 Dec; 38 Suppl 5:S98-S103. PMID: 31821636
Aims: The regulatory warnings about the safety of the synthetic midurethral slings (MUS) had a significant effect on how patients and physicians approach surgical management of stress urinary incontinence (SUI)....
16.
Drage L, Robson W, Mowbray C, Ali A, Perry J, Walton K, et al.
Immun Ageing . 2019 Jul; 16:16. PMID: 31338112
Background: Age is a significant risk factor for recurrent urinary tract (rUTI) infections, but the clinical picture is often confused in older patients who also present with asymptomatic bacteriuria (ASB)....
17.
Hughes G, Hall S, Laxton C, Sridhar P, Mahadi A, Hatton C, et al.
Nat Microbiol . 2019 Jun; 4(10):1692-1705. PMID: 31235958
The Mla pathway is believed to be involved in maintaining the asymmetrical Gram-negative outer membrane via retrograde phospholipid transport. The pathway is composed of three components: the outer membrane MlaA-OmpC/F...
18.
MacKenzie K, Davis J, Harding C, Aning J
Neurourol Urodyn . 2019 Apr; 38(5):1353-1362. PMID: 30980415
Aims: To evaluate the patient-reported outcome measures (PROMs) and urodynamic findings in men seeking intervention for lower urinary tract symptoms (LUTS) after robotic-assisted radical prostatectomy (RARP) in a regional referral...
19.
Uren A, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, et al.
Neurourol Urodyn . 2019 Feb; 38(3):996-1004. PMID: 30801826
Aims: To present the development of the International Consultation on Incontinence Questionnaire-underactive bladder (ICIQ-UAB) as the first patient reported outcome measure for the assessment of the symptoms and impact on...
20.
Abrams P, Eustice S, Gammie A, Harding C, Kearney R, Rantell A, et al.
Neurourol Urodyn . 2019 Jan; 38(2):838-856. PMID: 30648750
No abstract available.